Magnesium Isoglycyrrhizinate Reduces the Target-Binding Amount of Cisplatin to Mitochondrial DNA and Renal Injury through SIRT3
Open Access
- 28 October 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (21) , 13093
Abstract
Nephrotoxicity is the dose-limiting factor of cisplatin treatment. Magnesium isoglycyrrhizinate (MgIG) has been reported to ameliorate renal ischemia–reperfusion injury. This study aimed to investigate the protective effect and possible mechanisms of MgIG against cisplatin-induced nephrotoxicity from the perspective of cellular pharmacokinetics. We found that cisplatin predominantly accumulated in mitochondria of renal tubular epithelial cells, and the amount of binding with mitochondrial DNA (mtDNA) was more than twice that with nuclear DNA (nDNA). MgIG significantly lowered the accumulation of cisplatin in mitochondria and, in particular, the degree of target-binding to mtDNA. MgIG notably ameliorated cisplatin-induced changes in mitochondrial membrane potential, morphology, function, and cell viability, while the magnesium donor drugs failed to work. In a mouse model, MgIG significantly alleviated cisplatin-caused renal dysfunction, pathological changes of renal tubules, mitochondrial ultrastructure variations, and disturbed energy metabolism. Both in vitro and in vivo data showed that MgIG recovered the reduction of NAD+-related substances and NAD+-dependent deacetylase sirtuin-3 (SIRT3) level caused by cisplatin. Furthermore, SIRT3 knockdown weakened the protective effect of MgIG on mitochondria, while SIRT3 agonist protected HK-2 cells from cisplatin and specifically reduced platinum-binding activity with mtDNA. In conclusion, MgIG reduces the target-binding amount of platinum to mtDNA and exerts a protective effect on cisplatin-induced renal injury through SIRT3, which may provide a new strategy for the treatment of cisplatin-induced nephrotoxicity.Keywords
Funding Information
- National Natural Science Foundation of China (82274014, 82073928, 82073929)
- Leading technology foundation research project of Jiangsu province (BK20192005)
- Haihe Laboratory of Cell Ecosystem Innovation Fund (HH22KYZX0006)
- Sanming Project of Medicine in Shenzen Municipality (SZSM201801060)
- Ningxia Hui Autonomous Region (2018, RQ0161)
This publication has 70 references indexed in Scilit:
- Cisplatin Induces a Mitochondrial-ROS Response That Contributes to Cytotoxicity Depending on Mitochondrial Redox Status and Bioenergetic FunctionsPLOS ONE, 2013
- Interaction of Sirt3 with OGG1 contributes to repair of mitochondrial DNA and protects from apoptotic cell death under oxidative stressCell Death & Disease, 2013
- Evolving importance of kidney disease: from subspecialty to global health burdenThe Lancet, 2013
- The severity of acute kidney injury predicts progression to chronic kidney diseaseKidney International, 2011
- Fragmented mitochondria are sensitized to Bax insertion and activation during apoptosisAmerican Journal of Physiology-Cell Physiology, 2011
- Sirt3-Mediated Deacetylation of Evolutionarily Conserved Lysine 122 Regulates MnSOD Activity in Response to StressMolecular Cell, 2010
- Mechanisms of Cisplatin NephrotoxicityToxins, 2010
- Renal late effects in patients treated for cancer in childhood: A report from the Children's Oncology GroupPediatric Blood & Cancer, 2008
- A Mitochondrial Protein Compendium Elucidates Complex I Disease BiologyCell, 2008
- Nutrient-Sensitive Mitochondrial NAD+ Levels Dictate Cell SurvivalCell, 2007